PLCG1 and B-cell chronic lymphocytic leukemia: Finally, although PLCγ1 over-expression was clearly observed in CLL B cells, the mRNA assessment of PLCG1 was done using samples from 50 CLL patients and 11 healthy donors, which is not enough to determine whether this protein could be considered as a prognostic marker in CLL.